Related Experiment Video

Updated: May 25, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Bronchial asthma and obesity in childhood

Jana Krystofová1, Milos Jesenák, Peter Bánovcin

  • 1Comenius University in Bratislava, Jessenius Medical Faculty, University Hospital Martin, Department of Pediatrics, Slovak Republic. krystofova1@india.com

Acta Medica (Hradec Kralove)
|January 19, 2012
PubMed

Insights

Bronchial asthma and obesity are complex, multi-etiologic diseases that significantly impact patient quality of life and healthcare costs. Research is increasing to understand their reciprocal associations due to rising global prevalence.

Area of Science:

  • Pulmonology
  • Metabolic Diseases
  • Epidemiology

Background:

  • Bronchial asthma and obesity are increasingly prevalent chronic conditions.
  • Both diseases are complex and influenced by multiple factors.
  • Their co-occurrence significantly impacts patient health and healthcare systems.

Purpose of the Study:

  • To explore the intricate relationship between bronchial asthma and obesity.
  • To understand how these two conditions influence each other's development and progression.
  • To highlight the growing body of research investigating their reciprocal associations.

Main Methods:

  • Literature review of recent studies on asthma and obesity.
  • Analysis of epidemiological data on disease prevalence.
  • Examination of etiological factors contributing to both conditions.

Main Results:

  • Evidence suggests a significant bidirectional relationship between asthma and obesity.
  • Obesity is linked to increased asthma severity and reduced treatment efficacy.
  • Asthma may also influence metabolic pathways relevant to obesity development.

Conclusions:

  • The interplay between bronchial asthma and obesity is a critical area of public health concern.
  • Further research is needed to elucidate the precise mechanisms underlying their association.
  • Understanding these links is vital for improving patient outcomes and managing healthcare costs.

More Related Videos

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...